Company Data
HilleVax Inc.
Ticker
HLVX
Current Price
$1.83 -2.14%
Market Cap
$91.1M
Price Target
Refer to Report
Volume
89.4K
52wk Range
$1.55 - $20.22
Overview
HilleVax Inc is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing novel vaccines. The firm’s initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis (AGE) caused by norovirus infection.